MSB 2.52% $1.16 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-250

  1. 30,317 Posts.
    lightbulb Created with Sketch. 1836
    Oh for God's sake.

    MSB is spearheading new technology unlike what's gone on before.

    The clinical trials are set up in consultation with the FDA, which means what MSB wanted and what they got in terms of trial design are different things. And as has already been stated, there are variables in the control group of the ARDS including other treatments.

    People should calm down. Emotional reactions are never a good move.

    Also there's been bleating that supposedly MSB is targeting mums and dad investors.

    HARDLY!

    They are in the overwhelming minority. Just look at the register.

    Also the carrying on that anyone who talked positively about the stock is a shorter and has taken profits.

    Ridiculous.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.16
Change
-0.030(2.52%)
Mkt cap ! $1.370B
Open High Low Value Volume
$1.18 $1.22 $1.15 $4.226M 3.581M

Buyers (Bids)

No. Vol. Price($)
16 13475 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 17245 8
View Market Depth
Last trade - 13.37pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.